Search concepts
|
Selected Filters
|
- 2,050 - 2,100 out of 158,938 results
Search results
-
2023
Aortic Stress Activates an Adaptive Program in Thoracic Aortic Smooth Muscle Cells That Maintains Aortic Strength and Protects Against Aneurysm and Dissection in Mice
Zhang, C., Li, Y., Chakraborty, A., Li, Y., Rebello, K. R., Ren, P., Luo, W., Zhang, L., Lu, H. S., Cassis, L. A., Coselli, J. S., Daugherty, A., Lemaire, S. A. & Shen, Y. H., Feb 1 2023, In: Arteriosclerosis, thrombosis, and vascular biology. 43, 2, p. 234-252 19 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
A personal perspective on the development and future of cone-beam CT for image-guided radiotherapy
Jaffray, D. A., Jun 2023, In: Medical physics. 50, S1, p. 54-57 4 p.Research output: Contribution to journal › Review article › peer-review
-
A pH-Activatable Nanoprobe Labels Diverse Histologic Subtypes of Human Lung Cancer During Resection
Kennedy, G. T., Azari, F. S., Chang, A., Chang, A., Bou-Samra, P., Desphande, C., Delikatny, E. J., Eruslanov, E., Kucharczuk, J. C., Rice, D. C. & Singhal, S., Oct 2023, In: Molecular Imaging and Biology. 25, 5, p. 824-832 9 p.Research output: Contribution to journal › Article › peer-review
-
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors
Janku, F., Javle, M. M., Sen, S., Pant, S., Bramwell, L. G., Subbiah, V., Way, T., Wages, D. S., Wheeler, C. A., Suzuki, T., Saeki, K., Subach, R. A., Madden, T., Maier, G., Johansen, M. J., Cheung, K. & Falchook, G. S., May 15 2023, In: Cancer. 129, 10, p. 1537-1546 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma
Lopez, J., Lai-Kwon, J., Molife, R., Welsh, L., Tunariu, N., Roda, D., Fernández-García, P., Lladó, V., McNicholl, A. G., Rosselló, C. A., Taylor, R. J., Azaro, A., Rodón, J., Sludden, J., Veal, G. J., Plummer, R., Urruticoechea, A., Lahuerta, A., Mujika, K. & Escribá, P. V., Sep 21 2023, In: British journal of cancer. 129, 5, p. 811-818 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
Short, N. J., Muftuoglu, M., Ong, F., Nasr, L., Macaron, W., Montalban-Bravo, G., Alvarado, Y., Basyal, M., Daver, N., Dinardo, C. D., Borthakur, G., Jain, N., Ohanian, M., Jabbour, E., Issa, G. C., Qiao, W., Huang, X., Kanagal-Shamanna, R., Patel, K. P., Bose, P., & 7 others , Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 73.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
Cherng, H. J. J., Alig, S. K., Oki, Y., Nastoupil, L. J., Fayad, L., Neelapu, S. S., Turturro, F., Hagemeister, F., Craig, A. F. M., Macaulay, C. W., Rodriguez, M. A., Lee, H. J., McDonnell, T. J., Flowers, C. R., Vega, F., Green, M. R., Feng, L., Kurtz, D. M., Alizadeh, A. A., Davis, R. E., & 1 others , Apr 11 2023, In: Blood Advances. 7, 7, p. 1137-1145 9 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Razak, A. R. A., Wang, H. M., Chang, J. Y., Ahn, M. J., Munster, P., Blumenschein, G., Solomon, B., Lim, D. W. T., Hong, R. L., Pfister, D., Saba, N. F., Lee, S. H., van Herpen, C., Quadt, C., Bootle, D., Blumenstein, L., Demanse, D. & Delord, J. P., Nov 2023, In: Targeted oncology. 18, 6, p. 853-868 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes
Zeidan, A. M., Borate, U., Pollyea, D. A., Brunner, A. M., Roncolato, F., Garcia, J. S., Filshie, R., Odenike, O., Watson, A. M., Krishnadasan, R., Bajel, A., Naqvi, K., Zha, J., Cheng, W. H., Zhou, Y., Hoffman, D., Harb, J. G., Potluri, J. & Garcia-Manero, G., Feb 2023, In: American journal of hematology. 98, 2, p. 272-281 10 p.Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations -
A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance
Yap, T. A., LoRusso, P. M., Wong, D. J., Hu-Lieskova, S., Papadopoulos, K. P., Holz, J. B., Grabowska, U., Gradinaru, C., Leung, K. M., Marshall, S., Reader, C. S., Russell, R., Sainson, R. C. A., Seal, C. J., Shepherd, C. J., Germaschewski, F., Gliddon, D., Stern, O., Young, L., Brewis, N., & 2 others , Mar 1 2023, In: Clinical Cancer Research. 29, 5, p. 888-898 11 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
DiNardo, C. D., Hochhaus, A., Frattini, M. G., Yee, K., Zander, T., Krämer, A., Chen, X., Ji, Y., Parikh, N. S., Choi, J. & Wei, A. H., Mar 2023, In: Journal of cancer research and clinical oncology. 149, 3, p. 1145-1158 14 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
Strati, P., Jallouk, A., Deng, Q., Li, X., Feng, L., Sun, R., Adkins, S., Johncy, S., Cain, T., Steiner, R. E., Ahmed, S., Chihara, D., Fayad, L. E., Iyer, S. P., Horowitz, S., Nastoupil, L. J., Nair, R., Hassan, A., Daoud, T. E., Hawkins, M., & 8 others , 2023, In: Blood Advances. 7, 21, p. 6785-6789 5 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
Malhotra, M. K., Pahuja, S., Kiesel, B. F., Appleman, L. J., Ding, F., Lin, Y., Tawbi, H. A., Stoller, R. G., Lee, J. J., Belani, C. P., Chen, A. P., Giranda, V. L., Shepherd, S. P., Emens, L. A., Ivy, S. P., Chu, E., Beumer, J. H. & Puhalla, S., Apr 2023, In: Breast Cancer Research and Treatment. 198, 3, p. 487-498 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies
Boddu, P. C., Senapati, J., Ravandi-Kashani, F., Jabbour, E. J., Jain, N., Ayres, M., Chen, Y., Keating, M. J., Kantarjian, H. M., Gandhi, V. & Kadia, T. M., Feb 15 2023, In: Cancer. 129, 4, p. 580-589 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
Ponce, D. M., Alousi, A. M., Nakamura, R., Slingerland, J., Calafiore, M., Sandhu, K. S., Barker, J. N., Devlin, S., Shia, J., Giralt, S., Perales, M. A., Moore, G., Fatmi, S., Soto, C., Gomes, A., Giardina, P., Marcello, L. A., Yan, X., Tang, T., Dreyer, K., & 5 others , Mar 23 2023, In: Blood. 141, 12, p. 1389-1401 13 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
Jain, N., Senapati, J., Thakral, B., Ferrajoli, A., Thompson, P., Burger, J., Basu, S., Kadia, T., Daver, N., Borthakur, G., Konopleva, M., Pemmaraju, N., Parry, E., Wu, C. J., Khoury, J., Bueso-Ramos, C., Garg, N., Wang, X., Lopez, W., Ayala, A., & 6 others , May 23 2023, In: Blood Advances. 7, 10, p. 1958-1966 9 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)
Jung, H. A., Kim, M., Kim, H. S., Kim, J. H., Choi, Y. H., Cho, J., Park, J. H., Park, K. U., Ku, B. M., Park, S., Sun, J. M., Lee, S. H., Ahn, J. S., Park, K. & Ahn, M. J., Feb 2023, In: Journal of Thoracic Oncology. 18, 2, p. 223-231 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Merrill, M. H., Dahi, P. B., Redd, R. A., McDonough, M. M., Chen, Y. B., DeFilipp, Z., Herrera, A. F., Fisher, D. C., LaCasce, A. S., Odejide, O. O., Ng, S. Y., Jacobson, C. A., Merryman, R. W., Kim, A. I., Nieto, Y. L., Sauter, C. S., Shah, G. L., Zain, J. M., Armand, P. & Jacobsen, E. D., Aug 17 2023, In: Blood. 142, 7, p. 621-628 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
George, S., Heinrich, M. C., Somaiah, N., Oppelt, P., McLeod, R., Nishioka, S., Kundu, M. G., Qian, X., Kumar, P., Laadem, A., Lau, Y., Tran, B. P., Fallon, M., Dosunmu, O., Shi, J. & Naito, Y., Sep 15 2023, In: Clinical Cancer Research. 29, 18, p. 3659-3667 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations
Heymach, J., Opdam, F., Barve, M., Gibson, N., Sadrolhefazi, B., Serra, J. & Yamamoto, N., Mar 2023, In: Clinical Lung Cancer. 24, 2, p. e65-e68Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Dawson, M. A., Borthakur, G., Huntly, B. J. P., Karadimitris, A., Alegre, A., Chaidos, A., Vogl, D. T., Pollyea, D. A., Davies, F. E., Morgan, G. J., Glass, J. L., Kamdar, M., Mateos, M. V., Tovar, N., Yeh, P., Delgado, R. G., Basheer, F., Marando, L., Gallipoli, P., Wyce, A., & 11 others , Feb 1 2023, In: Clinical Cancer Research. 29, 4, p. 711-722 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies
Lachowiez, C. A., Loghavi, S., Zeng, Z., Tanaka, T., Kim, Y. J., Uryu, H., Turkalj, S., Jakobsen, N. A., Luskin, M. R., Duose, D. Y., Tidwell, R. S. S., Short, N. J., Borthakur, G., Kadia, T. M., Masarova, L., Tippett, G. D., Bose, P., Jabbour, E. J., Ravandi, F., Daver, N. G., & 7 others , Jul 2023, In: Blood cancer discovery. 4, 4, p. 276-293 18 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
Tabernero, J., Van Cutsem, E., Garralda, E., Tai, D., De Braud, F., Geva, R., van Bussel, M. T. J., Fiorella Dotti, K., Elez, E., de Miguel, M. J., Litwiler, K., Murphy, D., Edwards, M. & Morris, V. K., Mar 17 2023, In: The oncologist. 28, 3, p. 230-238 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors
Bauer, T. M., Moore, K. N., Rader, J. S., Simpkins, F., Mita, A. C., Beck, J. T., Hart, L., Chu, Q., Oza, A., Tinker, A. V., Imedio, E. R., Kumar, S., Mugundu, G., Jenkins, S., Chmielecki, J., Jones, S., Spigel, D. & Fu, S., Jul 2023, In: Targeted oncology. 18, 4, p. 517-530 14 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases
Garg, A. K., Hernandez, M., Schlembach, P. J., Bowers, J. R., McAleer, M. F., Brown, P., Gopal, R., Wiederhold, L., Swanson, T., Shah, S. J., Li, J., Ferguson, S. D., Philip, N. V., Degracia, L., Bloom, E. S. & Chun, S. G., Dec 1 2023, In: JNCI Cancer Spectrum. 7, 6, pkad093.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
Nze, C., Msaouel, P., Derbala, M. H., Stephen, B., Abonofal, A., Meric-Bernstam, F., Tannir, N. M. & Naing, A., Aug 2023, In: Cancers. 15, 15, 3806.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Yam, C., Mittendorf, E. A., Garber, H. R., Sun, R., Damodaran, S., Murthy, R. K., Ramirez, D., Karuturi, M., Layman, R. M., Ibrahim, N., Rauch, G. M., Adrada, B. E., Candelaria, R. P., White, J. B., Ravenberg, E., Clayborn, A., Ding, Q. Q., Symmans, W. F., Prabhakaran, S., Thompson, A. M., & 5 others , Jun 2023, In: Breast Cancer Research and Treatment. 199, 3, p. 457-469 13 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Senapati, J., Muftuoglu, M., Ishizawa, J., Abbas, H. A., Loghavi, S., Borthakur, G., Yilmaz, M., Issa, G. C., Dara, S. I., Basyal, M., Li, L., Naqvi, K., Pourebrahim, R., Jabbour, E. J., Kornblau, S. M., Short, N. J., Pemmaraju, N., Garcia-Manero, G., Ravandi, F., Khoury, J., & 4 others , Dec 2023, In: Blood cancer journal. 13, 1, 101.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Nelson, B. E., Tsimberidou, A. M., Fu, X., Fu, S., Subbiah, V., Sood, A. K., Rodon, J., Karp, D. D., Blumenschein, G., Kopetz, S., Pant, S. & Piha-Paul, S. A., Dec 2023, In: Oncologist. 28, 12, p. e1100-e1292Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation
Metts, J. L., Trucco, M., Weiser, D. A., Thompson, P., Sandler, E., Smith, T., Crimella, J., Sansil, S., Thapa, R., Fridley, B. L., Llosa, N., Badgett, T., Gorlick, R., Reed, D. & Gill, J., Feb 2023, In: Cancer medicine. 12, 4, p. 4270-4281 12 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
Roy, T., Barrows, E., Mainor, C., Collins, J., Lynce, F., Isaacs, C. & Pohlmann, P. R., Jun 2023, In: Contemporary Clinical Trials Communications. 33, 101110.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
Piha-Paul, S. A., Tseng, C., Tran, H. T., Gao, M., Karp, D. D., Subbiah, V., Tsimberidou, A. M., Kawedia, J. D., Fu, S., Pant, S., Yap, T. A., Morris, V. K., Kee, B. K., Blum Murphy, M., Lim, J. A. & Meric-Bernstam, F., Aug 2023, In: Cancer chemotherapy and pharmacology. 92, 2, p. 107-118 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phycoerythrin isolated from Rhodomonas salina induces apoptosis via ERK/Bak and JNK/Caspase-3 pathway in A549 cells
Zhao, X., Jiao, L., Liu, D., Yang, T., Zhang, Y., Zhou, A., Wen, Z., Zhang, K. & Xie, J., Apr 30 2023, In: International Journal of Biological Macromolecules. 235, 123838.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Pilot Educational Intervention to Support Primary Care Provider Performance of Skin Cancer Examinations
Nelson, K. C., Seiverling, E. V., Gonna, N., Berry, E., Stoos, E., Dorsey, C. N., Sepulveda, S., Vazquez, G., Doan, H. Q. & Haydu, L. E., Feb 2023, In: Journal of Cancer Education. 38, 1, p. 364-369 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells
Weng, J. R., Gopula, B., Chu, P. C., Hu, J. L. & Feng, C. H., Aug 1 2023, In: Chemico-Biological Interactions. 380, 110538.Research output: Contribution to journal › Article › peer-review
-
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
Janjigian, Y. Y., Shitara, K., Moehler, M., Garrido, M., Salman, P., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Bragagnoli, A. C., Liu, T., Schenker, M., Yanez, P., Tehfe, M., Kowalyszyn, R., Karamouzis, M. V., Bruges, R., Zander, T., Pazo-Cid, R., Hitre, E., Feeney, K., & 8 others , Apr 1 2023, In: Future Oncology. 19, 11, p. 739-752 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab
Spira, A., Girard, N., Krebs, M., Park, K., Shu, C., Dougherty, L. & Cho, B. C., Oct 1 2023, In: Future Oncology. 19, 33, p. 2213-2225 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R., & 42 others , Jan 15 2023, In: International journal of cancer. 152, 2, p. 239-248 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
Ma, J., Yang, X., Zhang, J., Antonoff, M. B., Wu, Q. & Ji, H., 2023, In: Translational Lung Cancer Research. 12, 3, p. 580-593 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer
Losada, J. N. Z., Sulpice, E., Combe, S., Almeida, G. S., Leach, D. A., Choo, J., Protopapa, L., Hamilton, M. P., McGuire, S., Gidrol, X., Bevan, C. L. & Fletcher, C. E., Mar 2023, In: Journal of Endocrinology. 256, 3, e220229.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., Aqeilan, R. I., Arama, E., Baehrecke, E. H., Balachandran, S., Bano, D., Barlev, N. A., Bartek, J., Bazan, N. G., & 208 others , May 2023, In: Cell death and differentiation. 30, 5, p. 1097-1154 58 p.Research output: Contribution to journal › Review article › peer-review
Open Access77 Scopus citations -
A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia
Fijalkowski, I., Wang, J., Jin, Q., Van Laere, J., Serafin, V., Crispino, J. D. & Ntziachristos, P., 2023, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Article › peer-review
Open Access -
Applicability and usage of dose mapping/accumulation in radiotherapy
Murr, M., Brock, K. K., Fusella, M., Hardcastle, N., Hussein, M., Jameson, M. G., Wahlstedt, I., Yuen, J., McClelland, J. R. & Vasquez Osorio, E., May 2023, In: Radiotherapy and Oncology. 182, 109527.Research output: Contribution to journal › Review article › peer-review
Open Access15 Scopus citations -
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
Rolfo, C., Giovannetti, E., Martinez, P., McCue, S. & Naing, A., Dec 2023, In: npj Precision Oncology. 7, 1, 26.Research output: Contribution to journal › Review article › peer-review
Open Access21 Scopus citations -
Applying HT-SAXS to chemical ligand screening
Brosey, C. A., Shen, R., Moiani, D., Jones, D. E., Burnett, K., Hura, G. L. & Tainer, J. A., Jan 2023, Small Angle Scattering Part B: Methods for Structural Interpretation. Tainer, J. A. (ed.). Academic Press Inc., p. 331-350 20 p. (Methods in Enzymology; vol. 678).Research output: Chapter in Book/Report/Conference proceeding › Chapter
3 Scopus citations -
Apposition of Fibroblasts With Metaplastic Gastric Cells Promotes Dysplastic Transition
Lee, S. H., Contreras Panta, E. W., Gibbs, D., Won, Y., Min, J., Zhang, C., Roland, J. T., Hong, S. H., Sohn, Y., Krystofiak, E., Jang, B., Ferri, L., Sangwan, V., Ragoussis, J., Camilleri-Broët, S., Caruso, J., Chen-Tanyolac, C., Strasser, M., Gascard, P., Tlsty, T. D., & 3 others , Aug 2023, In: Gastroenterology. 165, 2, p. 374-390 17 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Approach to Imaging of Mediastinal Masses
Ahuja, J., Strange, C. D., Agrawal, R., Erasmus, L. T. & Truong, M. T., Oct 2023, In: Diagnostics. 13, 20, 3171.Research output: Contribution to journal › Review article › peer-review
Open Access -
Approach to the Older Patient with Acute Myeloid Leukemia
Zimmer, M. & Kadia, T., Nov 2023, In: Current oncology reports. 25, 11, p. 1203-1211 9 p.Research output: Contribution to journal › Review article › peer-review
-
Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review
Navarro-Domenech, I., Behroozian, T., Hoskin, P., Johnstone, C., Recht, A., Menten, J., Oldenburger, E., van der Linden, Y. M., van der Velden, J. M., Nguyen, Q. N., Simone, C. B., Johnstone, P., Lutz, S., Milton, L., Andratschke, N., Willmann, J., Kazmierska, J., Spałek, M., Marta, G. N., Chow, E., & 1 others , May 31 2023, In: Annals of Palliative Medicine. 12, 3, p. 620-632 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
A practical guide to clinical photography prior to skin biopsy: key tips and proposed workflow
ISIC Technique Working Group, Nov 2023, In: Archives of Dermatological Research. 315, 9, p. 2661-2667 7 p.Research output: Contribution to journal › Article › peer-review